[Infectious complications after transplantation of autologous hemopoietic blood cells in patients with hematological malignancies].

Л. П. Менделеева(National Research Center for Hematology Russian Academy of Medical Sciences), Savchenko Vg(National Research Center for Hematology Russian Academy of Medical Sciences), Mitish Ne, Pokrovskaia Os, Kalinin Nn, Garanzha Ta, Gribanova Eo, Gretsov Em, Kostina Ié, Liubimova Ls, Kliasova Ga, Petrova Na
PubMed
January 1, 2005
Cited by 1

Related Papers

Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation
|Bone Marrow Transplantation|2014|195
Atlas of RNA sequencing profiles for normal human tissues
|Scientific Data|2019|142
Current Multiple Myeloma Treatment Strategies with Novel Agents: A European Perspective
|The Oncologist|2010|92
Thromboelastography, thrombin generation test and thrombodynamics reveal hypercoagulability in patients with multiple myeloma
|Leukemia & lymphoma/Leukemia and lymphoma|2015|59
Mitochondrial thioredoxin reductase regulates major cytotoxicity pathways of proteasome inhibitors in multiple myeloma cells
|Leukemia|2015|53